University of Virginia, Charlottesville, VA, USA.
Division of Microbiology, Calgary Laboratory Services, University of Calgary, Calgary, AB, Canada; Departments of Pathology & Laboratory Medicine, University of Calgary, Calgary, AB, Canada.
Adv Appl Microbiol. 2015;90:109-54. doi: 10.1016/bs.aambs.2014.09.002. Epub 2014 Nov 13.
Escherichia coli ST131 emerged during the early to mid-2000s is an important human pathogen, has spread extensively throughout the world, and is responsible for the rapid increase in antimicrobial resistance among E. coli. ST131 is known to cause extraintestinal infections, being fluoroquinolone resistant, and is associated with ESBL production most often due to CTX-M-15. Recent molecular epidemiologic studies using whole-genome sequencing and phylogenetic analysis have demonstrated that the H30 ST131 lineage emerged in early 2000s that was followed by the rapid expansion of its sublineages H30-R and H30-Rx. Escherichia coli ST131 clearly has all of the essential characteristics that define a high-risk clone and might be the quintessential example of an international multiresistant high-risk clone. We urgently need rapid cost-effective detection methods for E. coli ST131, as well as well-designed epidemiological and molecular studies to understand the dynamics of transmission, risk factors, and reservoirs for ST131. This will provide insight into the emergence and spread of this multiresistant sequence type that will hopefully lead to information essential for preventing the spread of ST131.
产志贺毒素大肠杆菌 ST131 于 21 世纪初出现,是一种重要的人类病原体,已在全球广泛传播,并导致大肠杆菌对抗菌药物的耐药性迅速增加。ST131 已知可引起肠道外感染,对氟喹诺酮类药物耐药,通常与 CTX-M-15 相关,可产生超广谱β-内酰胺酶。最近使用全基因组测序和系统发育分析的分子流行病学研究表明,H30 ST131 谱系于 21 世纪初出现,随后其亚谱系 H30-R 和 H30-Rx 迅速扩张。产志贺毒素大肠杆菌 ST131 显然具有定义高危克隆的所有基本特征,可能是国际多药耐药高危克隆的典型代表。我们迫切需要快速、具有成本效益的产志贺毒素大肠杆菌 ST131 检测方法,以及精心设计的流行病学和分子研究,以了解 ST131 的传播动态、危险因素和储主。这将深入了解这种多药耐药序列型的出现和传播,希望能为预防 ST131 传播提供必要的信息。